(Q47208132)
Statements
A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder (English)
Joseph R Calabrese
Robert D McQuade
William H Carson
Berit X Carlson
Linda M Rollin
Ronald N Marcus
Raymond Sanchez
Aripiprazole Study Group